KRAS and tubular adenoma: KRAS missense mutations were found in carcinomas (3 out of 8; mutation frequency = 37.5%), in villous adenomas (5 out of 10; mutation frequency = 50%) and in tubular adenomas (2 out of 9; mutation frequency = 22.2%).